Latest Breaking News On - Ono pharmaceutical - Page 1 : comparemela.com

Fate Therapeutics (NASDAQ:FATE) versus Protara Therapeutics (NASDAQ:TARA) Financial Comparison

Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Protara Therapeutics (NASDAQ:TARA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Analyst Ratings This is a summary of […]

Medical Moonshots: 3 Biotech Stocks Set to Skyrocket

Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended.

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Approval based on results from CheckMate -901, the first Phase 3 trial in this patient population with an immunotherapy-chemotherapy combination to demonstrate survival benefit versus.

Equillium to Present at the Jefferies Global Healthcare Conference

Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the.

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space